87 related articles for article (PubMed ID: 6557570)
21. Selection of a therapeutic agent for the treatment of chronic obstructive pulmonary disease in smokers.
Turino GM; Davies P; Dunlap R; Krell RD; Maycock AL; Rennard S; Stockley RA
Ann N Y Acad Sci; 1991 Dec; 624 Suppl():23-30. PubMed ID: 1686162
[No Abstract] [Full Text] [Related]
22. Neutrophil enzymes in the lung: regulation of neutrophil elastase.
Lonky SA; McCarren J
Am Rev Respir Dis; 1983 Feb; 127(2):S9-15. PubMed ID: 6402963
[No Abstract] [Full Text] [Related]
23. [Demonstration of a low-molecular protease inhibitor in human bronchial secretion].
Reichert R; Hochstrasser K; Werle E
Z Laryngol Rhinol Otol; 1972 Mar; 51(3):190-3. PubMed ID: 5027523
[No Abstract] [Full Text] [Related]
24. Effect of S-carboxymethylcysteine lysine salt on mucociliary clearance in rabbits with secretory cell metaplasia.
Daffonchio L; De Santi MM; Gardi C; Lungarella G; Omini C
Res Commun Mol Pathol Pharmacol; 1994 Oct; 86(1):59-74. PubMed ID: 7850257
[TBL] [Abstract][Full Text] [Related]
25. Mucus in chronic obstructive airway diseases.
Zimmermann I
Eur J Respir Dis Suppl; 1980; 111():37-9. PubMed ID: 6938409
[No Abstract] [Full Text] [Related]
26. Effects of MR889, a cyclic thiolic neutrophil elastase inhibitor, on rheologic properties of mucus.
Moretti M; Gorrini M; Donnetta AM; Baldini EV; Venturini R; Marchioni CF; Iadarola P; Luisetti M
Life Sci; 1994; 54(7):463-9. PubMed ID: 8309349
[TBL] [Abstract][Full Text] [Related]
27. [Study of proteolysis in the serum and bronchial secretions in chronic bronchopneumopathies and in various forms of primary pulmonary emphysema].
Brancaccio L
Arch Monaldi; 1975; 30(5-6):363-77. PubMed ID: 1234833
[No Abstract] [Full Text] [Related]
28. Substituted 2-pyrones, 2-pyridones, and other congeners of elasnin as potential agents for the treatment of chronic obstructive lung diseases.
Groutas WC; Stanga MA; Brubaker MJ; Huang TL; Moi MK; Carroll RT
J Med Chem; 1985 Aug; 28(8):1106-9. PubMed ID: 3848491
[TBL] [Abstract][Full Text] [Related]
29. Proteinase (elastase) inhibitors from the ciliated membranes of the human respiratory tract.
Hochstrasser K
Methods Enzymol; 1976; 45():869-74. PubMed ID: 1012039
[No Abstract] [Full Text] [Related]
30. [The "IgA secretory component complex" in bronchial mucus in patients with chronic obstructive lung disease under different therapy (author's transl)].
Rasche B; Curschmann P
Respiration; 1979; 37(2):97-108. PubMed ID: 87005
[TBL] [Abstract][Full Text] [Related]
31. Electrophoretic mobility of leukocyte elastase of normal subjects and patients with chronic obstructive pulmonary disease.
Taylor JC; Kueppers F
Am Rev Respir Dis; 1977 Sep; 116(3):531-6. PubMed ID: 409318
[No Abstract] [Full Text] [Related]
32. Control of elastic tissue destruction by elastase inhibitors.
Hornebeck W; Bellon G; Brechemier D; Godeau G; Robert L
Prog Clin Biol Res; 1981; 54():233-46. PubMed ID: 6165025
[No Abstract] [Full Text] [Related]
33. Increased expression of human calcium-activated chloride channel 1 is correlated with mucus overproduction in the airways of Chinese patients with chronic obstructive pulmonary disease.
Wang K; Feng YL; Wen FQ; Chen XR; Ou XM; Xu D; Yang J; Deng ZP
Chin Med J (Engl); 2007 Jun; 120(12):1051-7. PubMed ID: 17637221
[TBL] [Abstract][Full Text] [Related]
34. [Bronchial mucus modifiers, antioxidants and antiproteases].
Polu JM; Chabot F; Wallaert B
Rev Mal Respir; 1993; 10(2):87-100. PubMed ID: 8502804
[No Abstract] [Full Text] [Related]
35. The pathogenesis of emphysema: the elastase:antielastase hypothesis 30 years later.
Shapiro SD
Proc Assoc Am Physicians; 1995 Oct; 107(3):346-52. PubMed ID: 8608421
[TBL] [Abstract][Full Text] [Related]
36. The role of proteinases in the pathogenesis of chronic bronchitis.
Stockley RA
Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 2):S109-13. PubMed ID: 7952644
[TBL] [Abstract][Full Text] [Related]
37. Ultrasonic method of sputum homogenization and its application in the study of the enzymic content of sputum.
Girard F; Tournier JM; Polu JM; Puchelle E; Beck G; Sandoul P
Clin Chim Acta; 1981 Jun; 113(1):105-9. PubMed ID: 6263524
[No Abstract] [Full Text] [Related]
38. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis.
Meyer KC; Zimmerman J
J Lab Clin Med; 1993 May; 121(5):654-61. PubMed ID: 8386737
[TBL] [Abstract][Full Text] [Related]
39. [Elastase-type endopeptidase of fibroblasts. Effect of metalloprotease inhibitors].
Bernard E; Hornebeck W; Robert L
C R Acad Sci III; 1995 Feb; 318(2):179-82. PubMed ID: 7757812
[TBL] [Abstract][Full Text] [Related]
40. [Pulmonary injury by proteases of exogenous and endogenous origin].
Trojani FT
Clin Ter; 1994 Aug; 145(8):171-3. PubMed ID: 7955965
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
